Colon and Rectal Cancer

Errata for Colon and Rectal Cancer

Submit your own errata for this product.


The errata list is a list of errors and their corrections that were found after the product was released. If the error was corrected in a later version or reprint the date of the correction will be displayed in the column titled "Date Corrected".

The following errata were submitted by our customers and approved as valid errors by the author or editor.

Color Key: Serious Technical Mistake Minor Technical Mistake Language or formatting error Typo Question Note Update



Version Location Description Submitted By Date Submitted Date Corrected
Printed
Page 28

2nd from last para- 'designate' has been changed to 'designated.'

Anonymous    Sep 01, 2000
Printed
Page 114

Since publication of the 1st edition of CRC, Camptosar (irinotecan) has been approved as first-line therapy for CRC; the bullet for Irinotecan has been replaced with: Irinotecan (Camptosar, CPT-11) was first approved in 1998 for colorectal cancer patients whose tumors failed to respond to 5-FU, and was approved in April 2000 as first-line therapy. Combining irinotecan with other drugs is now being studied.

Anonymous    Sep 01, 2000
Printed
Page 187

'outwardly' in the text under the illustration is now 'outward.'

Anonymous    Sep 01, 2000
Printed
Page 228

last para- the word 'or' has been added before the word 'passage.'

Anonymous    Sep 01, 2000
Printed
Page 491

"Formula" has been changed to "Formulae".

Anonymous    Sep 01, 2000
Printed
Page 510

Kaye Oslon is now Kaye Olson.

Anonymous    Sep 01, 2000